Lateral Epicondylitis (Tennis Elbow)
Off-label use with two RCTs showing significant pain reduction at 7-12 weeks compared to topical NSAID and conventional physiotherapy.
Patienten-Zusammenfassung
- Ist dies FDA-zugelassen fuer diese Anwendung?
- No — investigated off-label. The FDA cleared medicinal leeches in 2004 only for venous congestion in microsurgical reconstruction (K040187). Use for tennis elbow is supported by published research but not FDA-evaluated.
- Welche Evidenz existiert?
- Two small randomized trials (Bäcker 2011, n=49; Stange 2012, n=31) found single-session leech therapy reduced tennis elbow pain compared to NSAID gel at 7 days, with benefit persisting through about 12 weeks. The trials are from a German research group, are small, and long-term outcomes (beyond 6 months) are not well studied. This does not replace standard treatments such as physical therapy, eccentric loading exercises, or, in some cases, steroid injection.
- Hauptrisiken
- Bleeding and oozing from each bite site for several hours, sometimes up to 24 hours
- Itching, redness, and irritation at the bite sites for days to weeks
- Mild bruising around the elbow
- Local skin infection or, rarely, Aeromonas infection from leech gut bacteria
- Allergic reaction to leech saliva (uncommon)
- Small permanent scars at the bite sites
- Wer dies nicht in Betracht ziehen sollte
- Patients taking blood thinners such as warfarin, apixaban, rivaroxaban, dabigatran, or heparin
- Patients with hemophilia or other inherited bleeding disorders
- Patients with severe anemia (hemoglobin under 10 g/dL)
- Patients with a weakened immune system, especially severe neutropenia
- Patients with an active skin infection at the elbow
- Patients who had a steroid injection in the elbow within the last 4 weeks
- Pregnant patients (relative caution, especially first and third trimester)
- Was Sie Ihren Kliniker fragen sollten
- Have I tried first-line treatments such as activity modification, eccentric loading exercises, and physical therapy?
- How does leech therapy compare with steroid injection, platelet-rich plasma, or surgery for my severity?
- What is the realistic chance it will help me, and for how long?
- What is the practitioner's training, supplier, and Aeromonas prevention plan?
- What is the cost, and is it covered by insurance? (usually not, as off-label)
- What is the plan if pain returns — repeat session, injection, or referral?
- Are there any restrictions on lifting or gripping after the session, and for how long?
- Wann dringende medizinische Versorgung suchen
- Bleeding from a bite site lasting more than 24 hours
- Spreading redness, warmth, pus, or red streaks around the bite sites
- Fever above 38.0 C / 100.4 F or chills
- Sudden severe elbow pain, swelling, or loss of arm strength
- Hives, facial swelling, throat tightness, or breathing difficulty
Was dies NICHT bedeutet
- It does not mean leech therapy is FDA-approved for tennis elbow — it is not.
- It does not mean leeches fix the underlying tendon problem — exercise rehabilitation remains the foundation of treatment.
- It does not mean leech therapy is better than physical therapy or eccentric loading exercises — those have stronger long-term evidence.
- It does not mean every patient improves — individual results vary, and some patients see no benefit.
Sicherheits-Querverweise
Clinical Profile
- Category
- musculoskeletal
- ICD-10
- M77.10, M77.11, M77.12
- Safety tier
- low
Evidence Summary
A single randomized controlled trial (2011, n=40) compared one session of local leech therapy (2-4 leeches) to a 30-day course of topical diclofenac in chronic lateral epicondylitis of at least one month's duration. At day 7 the pain sum score fell from 143.7 to 95.3 in the leech group versus 131.6 to 134.7 with diclofenac (mean difference -49.0; 95% CI -82.9 to -15.1; P=0.0075); by day 45 the between-group pain difference had narrowed as diclofenac caught up, but functional disability (DASH) still favored the leech group (P=0.0007). Proposed mechanisms combine local anti-inflammatory effects of leech salivary components with analgesic and local decongestant ('bloodletting') effects. Evidence rests on this single small trial; long-term outcomes beyond about six weeks are not well characterized, and use remains investigational.
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)
Key Trials
- Bäcker M et al. (2011), n=40 · PMID 21368667 · ASH analysis →
- Stange R et al. (2012), n=31
Detailed Trial Entries
2 trials indexed in the ASH RCT Library with full Study Profile, GRADE rating, and clinical implications:
- Randomized controlled trial with medical leeches in patients with chronic lateral epicondylitis (tennis elbow)
Stange R, Moser C, Hopfenmueller W, Mansmann U, Uehleke B (2012) · Complementary Therapies in Medicine · n=52 · GRADE low
- Effectiveness of leech therapy in chronic lateral epicondylitis: a randomized controlled trial
Bäcker M, Lüdtke R, Afra D, Cesur Ö, Langhorst J, Fink M, Bachmann J, Dobos GJ, Michalsen A (2011) · The Clinical Journal of Pain · n=40 · GRADE low
Contraindications
- Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
- Hemophilia or other bleeding disorder
- Severe anemia (Hb <10 g/dL)
- Active bacteremia or sepsis
- Known hypersensitivity to leech salivary proteins
- Pregnancy (relative — first/third trimester)
- Immunocompromised state with severe neutropenia
- Recent local corticosteroid injection (<4 weeks)
Related Conditions
Knee Osteoarthritis
Off-label use with three RCTs showing pain and function improvement comparable to NSAID gel at 3 months in mild-to-moderate symptomatic knee OA.
Thumb Carpometacarpal (CMC-1) Osteoarthritis
Off-label use with RCT evidence: single-session leech therapy reduces pain and improves function in CMC-1 (basal thumb) OA at 8 weeks.
Plantar Fasciitis
Off-label use with one RCT showing significant heel pain reduction at 6 weeks compared to conservative care.
Fibromyalgia
Investigational adjunctive use; one small pilot suggests transient improvement in tender-point and quality-of-life scores. Not a primary treatment.